Partner Headlines - TEVA

  1. Investors Rewarded With Treats, Not Tricks, As Dow And S&P Close ...

    Benzinga
  2. Teva ups full-year EPS outlook

    IBD
  3. UPDATE: Teva Posts Stronger-Than-Expected Q3 Profit, Lifts Forecast

    Benzinga
  4. Earnings Scheduled For October 30, 2014

    Benzinga
  5. Lannett Co. Gets Growth Rx In Generic Drugs Group

    IBD
  6. IPO Calendar: Biotech Companies Lead List Of 7 IPOs

    IBD
  7. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With ...

    Benzinga
  8. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD
  9. Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene

    IBD
  10. Teva Reports Results of Strategic Review, Sees 14 Pipeline Projects ...

    Benzinga
  11. Fast Money Halftime Report Final Trade From October 2 - Twitter ...

    Benzinga
  12. Insys Therapeutics Up On Bullish Analyst Initiation

    IBD
  13. Teva Announces UK High Court Gives Positive Judgment In The Company's ...

    Benzinga
  14. 4 Biotechs That Might Be Bought Soon

    IBD
  15. Notable Hedge Funds Disclose Additions And Reductions To Holdings

    Benzinga
  16. Jana Partners LLC Files its 13F

    Benzinga
  17. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With ...

    Benzinga
  18. Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats

    IBD
  19. Did George Soros Sell His Stake In Israeli Based SodaStream Due ...

    Benzinga
  20. 5 Drug Companies Profiting From Generics

    Benzinga
  21. Top 5 Earnings Reports To Watch After The Close Tue.

    IBD
  22. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD
  23. George Soros Reveals His Largest Stake

    GuruFocus
  24. Sofinnova Ventures Closes $500M Fund

    FoxBusiness
  25. Israel's Market Appears Unfazed By Rising Conflict

    IBD
  26. George Soros Keeps Buying TEVA, EQT, YPF, EGN, CZR And Keeps ...

    GuruFocus
  27. UPDATE: Teva Announces FDA Acceptance of NDA For Inhaler

    Benzinga
  28. 4 Top Performing Health Care Stocks With More Potential Upside

    Benzinga
  29. Salix, Akorn, Regeneron Lead Drug Stock Rally

    IBD
  30. Top 4 Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  31. Diamond Hill Capital Comments on Teva Pharmaceutical Industries ...

    GuruFocus
  32. Diamond Hill Select Fund Commentary - First Quarter 2014

    GuruFocus
  33. Teva Pharmaceutical

    IBD
  34. Generic-Drug Makers Climb Ranks; Several In Buy Range

    IBD
  35. Teva Turmoil: Shares Up, Board Trimmed, CEO To Retire

    Benzinga
  36. Wells Fargo Initiates Coverage On The Pharmaceutical Space

    Benzinga
  37. Top Guru Held Asian Companies of the First Quarter

    GuruFocus
  38. Teva to buy Labrys Biologics

    IBD
  39. Chicago sues painkiller firms

    IBD
  40. Benzinga's M&A Chatter for Tuesday June 3, 2014

    Benzinga
  41. Teva Acquiring Labrys Biologics For Migraine Drug

    IBD
  42. Richard Snow's Top Five Highlight Finance and Healthcare Sectors

    GuruFocus
  43. Benzinga's M&A Chatter for Wednesday May 7, 2014

    Benzinga
  44. ETF Outlook For Tuesday May 6, 2014 (EUFN, ITA, EIS, UAE)

    Benzinga
  45. Wrong Marketing Lesson by Big Pharma

    GuruFocus
  46. Sterne Agee Sees Mixed Factors For Teva Pharmaceutical Industries ...

    Benzinga
  47. Teva EPS tops; rivals seen?

    IBD
  48. Market Wrap For May 1: Markets Mixed To Start The New Month

    Benzinga
  49. Earnings Scheduled For May 1, 2014

    Benzinga
  50. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
  51. Actavis Reporting Q1 Earnings Amid Merger Frenzy

    IBD
  52. US Stock Futures Up Ahead Of Earnings, Consumer Confidence Data

    Benzinga
  53. Morning Market Losers

    Benzinga
  54. Benzinga's Top #PreMarket Losers

    Benzinga
  55. UPDATE: Teva, Oncogenex Offer Top-Line Survival Results of Phase ...

    Benzinga
  56. Nasdaq Could Be in for a Bounce

    FoxBusiness
  57. Actavis got a Pfizer

    IBD
  58. Teva Settles Patent Litigation with Pfizer on Celebrex; Has Received ...

    Benzinga
  59. Sterne Agee Sees Teva Pharmaceutical Outperformance Continuing

    Benzinga
  60. Teva Unveils Generic Lunesta Tablets in US

    Benzinga
  61. Teva Announces First Approval and Launch of Generic Lovaza® Capsules ...

    Benzinga
  62. Market Wrap For April 7: Bears In Complete Control As Markets ...

    Benzinga
  63. Citigroup Slaps $70 Price Target on Teva, Highest on Street

    Benzinga
  64. Market Wrap For March 31: Stocks Rally As Yellen Confirms Support ...

    Benzinga
  65. Analyst Offers Insight on Favorable FDA Ruling for Teva Pharma

    Benzinga
  66. Market Wrap For March 28: Markets Still Positive Despite Giving ...

    Benzinga
  67. Teva Offers Most Attractive Risk-Reward Profile, Citigroup Says

    Benzinga
  68. UPDATE: Goldman Sachs Upgrades Teva Pharmaceutical Industries

    Benzinga
  69. Forest Laboratories' Recovery

    GuruFocus
  70. Should You Buy Actavis?

    GuruFocus
  71. Horizon Pharma Banks On Two-For-One Arthritis Drugs

    IBD
  72. UPDATE: JP Morgan Upgrades Teva Pharmaceuticals

    Benzinga
  73. UPDATE: Morgan Stanley Upgrades Teva Pharmaceutical Industries ...

    Benzinga
  74. Benzinga's Top Upgrades

    Benzinga
  75. US Stock Futures Edge Higher Ahead Of Consumer Sentiment Report

    Benzinga
  76. Pfizer Loses Patent On Celebrex, Plans To Appeal

    IBD
  77. Pfizer Loses Bid to Hold Celebrex Exclusivity to '15

    FoxBusiness
  78. Will Horizon Pharma Spike Again On Quarterly Report?

    IBD
  79. UPDATE: Barclays Upgrades Teva Pharmaceutical Industries Limited ...

    Benzinga
  80. Teva upgraded on drug launch

    IBD
  81. Teva Upgraded On Strong Launch Of Next-Gen Copaxone

    IBD
  82. Weekly 52-Week Highs Highlight: COV, EQT, XLNX, TEVA

    GuruFocus
  83. UPDATE: CRT Capital Initiates Coverage on OncoGenex

    Benzinga
  84. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With ...

    Benzinga
  85. Insys Recovers From Stock Hit Tied To Fed Probe

    IBD
  86. Generic-Drug Makers Actavis, Mylan To Report Q4 Soon

    IBD
  87. #PreMarket Primer: Friday, February 7: Jobs Friday

    Benzinga
  88. Teva Pharmaceuticals A Giant In Generic Drugs

    IBD
  89. UPDATE: Teva Pharmaceutical Posts Upbeat Q4 Earnings

    Benzinga
  90. Earnings Scheduled For February 6, 2014

    Benzinga
  91. Market Wrap For January 29: Markets Lower on Fed Taper, Emerging ...

    Benzinga
  92. Stocks Hitting 52-Week Highs

    Benzinga
  93. Special Situations Alert: Details Behind Why I Bought PATH

    GuruFocus
  94. Teva, Active Biotech Say Remain Committed to Development of NERVENTRA

    Benzinga
  95. Benzinga's M&A Chatter for Tuesday January 21, 2014

    Benzinga
  96. NuPathe Terminates Agreement With Endo Pharma and Enters Into ...

    Benzinga
  97. US Stock Futures Up; Alcoa Earnings, Jobless Claims Data In Focus

    Benzinga
  98. Drug Mergers Queuing Up

    IBD
  99. Forest Buying Aptalis; Teva Bids For NuPathe Vs. Endo

    IBD
  100. Morning Market Movers

    Benzinga
Trading Center